Results 291 to 300 of about 390,067 (339)
Some of the next articles are maybe not open access.

Lithium

2008
Lithium utility and toxicity are reviewed. Lithium continues to be the most useful agent available for the prophylaxis and treatment of bipolar illness. Lithium augmentation of antidepressants is useful in treatment-resistant unipolar depression. Utility in other psychiatric disorders, such as schizoaffective, alcoholism, or aggressive behavior, is ...
openaire   +2 more sources

Lithium phosphide/lithium chloride coating on lithium for advanced lithium metal anode

Journal of Materials Chemistry A, 2018
Lithium metal has been regarded as an ideal anode material for high-energy-density batteries.
Hongzhi Mao   +6 more
openaire   +2 more sources

Parkinsonian symptoms with lithium, lithium-neuroleptic, and lithium-antidepressant treatment

Journal of Affective Disorders, 1983
Eighty-one patients treated for a least 3 months with lithium were examined for the presence of parkinsonian symptoms. Twenty-four patients were receiving treatment with lithium alone, 30 with lithium and 1 or more neuroleptics, and 27 with lithium and antidepressant. Twenty-four of the patients were found to be free from parkinsonian symptoms.
Zoltán Rihmer   +2 more
openaire   +3 more sources

Estimation of Lithium Dose Requirement by Lithium Clearance, Serum Lithium and Saliva Lithium following a Loading Dose of Lithium Carbonate

Neuropsychobiology, 1981
Renal lithium clearance and the serum lithium levels following a single oral loading dose of lithium were used as measures to predict lithium dose requirement during long-term maintenance at 3 different psychiatric centers in North America. Saliva lithium values were also investigated at one of the centers. The correlation between lithium clearance and
P. Grof   +3 more
openaire   +3 more sources

Lithium in children of lithium-responding parents

Psychiatry Research, 1981
Six offspring of manic-depressive patients, whose parents were lithium responders, were selected on the basis of their incapacitating psychopathology for treatment with lithium. The children ranged in age from 6 to 12. A double-blind, crossover design was used over 16-18 weeks. Weekly ratings were done, and average evoked potentials (EPs) were measured
Donald H. McKnew   +6 more
openaire   +3 more sources

Lithium

Annual Review of Pharmacology, 1971
J M, Davis, W E, Fann
openaire   +3 more sources

Lithium Carbonate-Lithium Bromide

2001
(Li2CO3) [554-13-2] CLi2O3 (MW 73.89) InChI = 1S/CH2O3.2Li/c2-1(3)4;;/h(H2,2,3,4);;/q;2*+1/p-2 InChIKey = XGZVUEUWXADBQD-UHFFFAOYSA-L (LiBr) [7550-38-8] BrLi (MW 86.85) InChI = 1S/BrH.Li/h1H;/q;+1/p-1 InChIKey = AMXOYNBUYSYVKV-UHFFFAOYSA-M (reagent for dehydrohalogenation of α-halo ketones) Physical Data: see ...
Mark C. McMills, Dennis L. Wright
openaire   +2 more sources

Saliva lithium and lithium therapy

American Journal of Psychiatry, 1979
Roy J. Mathew   +4 more
openaire   +3 more sources

Lithium-Lithium Scattering

Physical Review, 1966
J. M. Blair, L. L. Pinsonneault
openaire   +2 more sources

Home - About - Disclaimer - Privacy